The Financial Analyst II for the Clinical Trials Office (CTO) reports to the Manager of Financial Services in the CTO and provides administrative oversight of financial activities for clinical research studies managed within the Wilmot Cancer Institute (WCI). Working under general guidance with considerable latitude for independent judgment, the role manages clinical-trial financial and contractual terms, patient-charge and insurance-reimbursement decisions, research billing compliance, sponsor reimbursements, compensation, and other payments. The position develops and negotiates study-specific budgets for industry-supported investigator-initiated, cooperative-group, and industry-initiated research across all phases of clinical research. This work supports approximately $10 million in annual expenditures and 400–500 protocol budgets and amendments per year. The analyst coordinates with investigators, research teams, industry representatives, and University and hospital offices to ensure required procedures and labor are accurately accounted for and priced. The role also manages contract and budget amendments or extensions, OnCore calendar and budget processes, and study-related financial records.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level